Overview

Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether the pharmacokinetics (body concentrations/metabolism of the drug) of Saxagliptin and Dapagliflozin are affected when they are administered together
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Dapagliflozin
Saxagliptin